Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ag-D-CIK Combined With Chemotherapy for Gastric Cancer
NCT02215837Phase 2Unknown
- Sponsor
- Shenzhen Hornetcorn Biotechnology Co., Ltd.
- Start
- Aug 2014
- Primary completion
- May 2018
- Modality
- Whole Cell Cancer Vaccines, Cytokines & Interferons, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of Ag-D-CIK in gastric cancer (GC), sponsored by Shenzhen Hornetcorn Biotechnology Co., Ltd.. Status: unknown.
02
Drugs
Ag-D-CIK
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT02215837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02215837.